Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ProPhase Labs, Inc. Director's Dealing 2024

Mar 19, 2024

34999_dirs_2024-03-19_7e13eb43-0045-488b-a5b9-bb4ec5797067.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2024-03-17

Reporting Person: Karkus Ted William (Director, CEO & CHAIRMAN, 10% Owner)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-03-17 Option (right to buy) $6.00 A 400000 Disposed 2031-03-17 Common Stock (400000) Direct

Footnotes

F1: Options shall vest and become exercisable in four equal installments, with 25% of such award vesting and becoming exercisable on the grant date and the remainder vesting and becoming exercisable in equal annual installments on the first, second and third anniversaries of the grant date.